Scottish Medicines Consortium Archives -

Patients with bladder cancer in Scotland will be the first in the UK to claim access to maintenance

Scotland backs Bavencio for bladder cancer after NICE says no

https://pharmaphorum.com/news/scotland-backs-bavencio-for-bladder-cancer-after-nice-says-no/

Scotland backs rare blood cancer drug Poteligeo rejected by NICE

Phil Taylor AstraZeneca, Boehringer Ingelheim, Calquence, Eli Lilly, Kyowa Kirin, NHS, nintedanib, Olumiant, Oncology, Poteligeo, Scotland, Scottish Medicines Consortium, Servier 0 Comment

A north-south divide has emerged in UK medicines access after the Scottish Medicines Consortium (SMC) okayed Kyowa Kirin’s

Scotland backs rare blood cancer drug Poteligeo rejected by NICE

https://pharmaphorum.com/news/scotland-backs-rare-blood-cancer-drug-poteligeo-rejected-by-nice/

News

Double first for Scotland as it backs Roche’s Rozlytrek, Novartis’ Zolgensma

Phil Taylor HEOR, NHS, Novartis, Roche, Rozlytrek, Scotland, Scottish Medicines Consortium, Zolgensma 0 Comment

The Scottish Medicines Consortium (SMC) has said Roche’s Rozlytrek can be used by NHS Scotland for the treatment

Double first for Scotland as it backs Roche’s Rozlytrek, Novartis’ Zolgensma

https://pharmaphorum.com/news/double-first-for-scotland-as-it-backs-roches-rozlytrek-novartis-zolgensma/

Keeping up the PACE at the Scottish Medicines Consortium

Market Access/ News/ News

Scotland backs Merck/Pfizer’s Bavencio combo for kidney cancer

Phil Taylor Bavencio, immuno-oncology, Inlyta, Merck KGaA, Oncology, Pfizer, renal cell carcinoma, Scottish Medicines Consortium 0 Comment

The Scottish Medicines Consortium (SMC) backed NHS use of nine new medicines at its meeting this week, including

Scotland backs Merck/Pfizer’s Bavencio combo for kidney cancer

https://pharmaphorum.com/news/scotland-backs-merck-pfizers-bavencio-combo-for-kidney-cancer/

Market Access/ News/ News

After a nay from NICE, Scotland says aye to J&J’s Spravato

Phil Taylor Cablivi, Janssen, NICE, Perjeta, Polivy, Roche, Sanofi, Scottish Medicines Consortium, Spravato 0 Comment

NHS patients with treatment-resistant depression in Scotland will be able to access Johnson & Johnson’s Spravato, a drug

After a nay from NICE, Scotland says aye to J&J’s Spravato

https://pharmaphorum.com/news/after-a-nay-from-nice-scotland-says-aye-to-jjs-spravato/

Market Access/ News/ News/ News/ Oncology

Scotland backs AZ’s Lynparza for first-line ovarian cancer maintenance

Phil Taylor AstraZeneca, Health Technology Assessment, Lynparza, Merck & Co, Oncology, ovarian cancer, Scotland, Scottish Medicines Consortium 0 Comment

The Scottish Medicines Consortium (SMC) has backed routine funding of AstraZeneca and MSD’s Lynparza as a maintenance treatment

Scotland backs AZ’s Lynparza for first-line ovarian cancer maintenance

https://pharmaphorum.com/news/scotland-backs-azs-lynparza-for-first-line-ovarian-cancer-maintenance/

Market Access/ Views & Analysis/ Views and analysis

Keeping up the PACE at the Scottish Medicines Consortium (SMC)

Leela Barham PACE, patient centricity, Scotland, Scottish Medicines Consortium, SMC 0 Comment

There are many ways that patient centricity could be delivered when doing a health technology assessment (HTA). The

Keeping up the PACE at the Scottish Medicines Consortium (SMC)

https://pharmaphorum.com/views-analysis-market-access/keeping-up-the-pace-at-the-scottish-medicines-consortium-smc/

Radiology technician examens mammography test

Market Access/ News/ News/ News/ Oncology/ UK & Europe

Pfizer’s Ibrance available across UK after thumbs up in Scotland

Richard Staines breast cancer, market access, NICE, Novartis, Pfizer, Scottish Medicines Consortium 0 Comment

Around 800 women have received the drug for free.

Pfizer’s Ibrance available across UK after thumbs up in Scotland

https://pharmaphorum.com/news/ibrance-available-across-uk-scottish/

News/ UK & Europe

Eisai bemoans UK’s north-south cancer divide

Richard Staines Bayer, cancer, Eisai, NICE, Scottish Medicines Consortium, thyroid cancer 0 Comment

Lenvima available in Scotland, not England.

Eisai bemoans UK’s north-south cancer divide

https://pharmaphorum.com/news/eisai-bemoans-north-south-thyroid-cancer-divide/

Trending

Scottish Medicines Consortium

Login